Publications by authors named "K A McLachlan"
Background: Treatments for inflammatory bowel disease (IBD) remain limited, and cannabis-based medicinal products (CBMPs) provide promise in addressing inflammation and pain. However, long-term data on CBMP efficacy in IBD are scarce. This study examines health-related quality of life (HRQoL) changes in IBD patients treated with CBMPs.
View Article and Find Full Text PDFBackground: Generalized anxiety disorder (GAD) is a common mental health condition. The endocannabinoid system has become a focus for new therapies, increasing interest in cannabis-based medicinal products (CBMPs). This study uses data from the UK Medical Cannabis Registry (UKMCR) to investigate real-world outcomes and safety of different CBMP formulations in GAD patients.
View Article and Find Full Text PDFGlobal assessment of swallow function (GASF) following VMAT radiotherapy for head and neck squamous cell carcinoma.
Tech Innov Patient Support Radiat Oncol
December 2024
Article Synopsis
- The study looked at how well people can swallow before and after they received special radiation treatment for cancers in the throat area.
- 175 patients were tested to see if their swallowing ability changed 6 months after treatment, and many showed a drop in their ability to eat or drink normally.
- The results showed some improvements for a few, but many had trouble swallowing and some even developed jaw stiffness after the radiation.
Adolescents with Fetal Alcohol Spectrum Disorder (FASD) often have challenges with executive functioning (EF), which impacts their ability to self-regulate. In this study, 23 adolescents with FASD completed a self-regulation intervention. The intervention was a manualized Teen Adaptation of the Alert Program®.
View Article and Find Full Text PDFBackground: Screening for fetal alcohol spectrum disorder (FASD) has been identified as a promising approach to improve recognition, understanding and effective response to the unique needs of those with FASD in criminal legal settings. However, to date, there has been limited synthesis of relevant screening tools, indicators, or implementation considerations in this context.
Aims: The present review aimed to synthesise evidence and develop a conceptual framework for understanding how, when, why, for whom and by whom FASD screening tools, items and/or indicators and characteristics serve to accurately identify people with FASD in criminal legal contexts, with consideration of individual and system needs relevant to effective implementation and response.